What is he best known for?
The fields of study he is best known for:
- Enzyme
- Organic chemistry
- Gene
Peter Wipf focuses on Biochemistry, Stereochemistry, Combinatorial chemistry, Organic chemistry and Total synthesis.
His study looks at the relationship between Biochemistry and fields such as Cell biology, as well as how they intersect with chemical problems.
His biological study spans a wide range of topics, including Stereoisomerism, Alkene, Peptide and Stereoselectivity.
His Combinatorial chemistry research focuses on Yield and how it relates to Phase.
His Total synthesis research is multidisciplinary, incorporating perspectives in Natural product and Absolute configuration.
His work carried out in the field of Mitochondrion brings together such families of science as Lipid peroxidation, Reactive oxygen species, Cardiolipin and Programmed cell death.
His most cited work include:
- Nanoparticles in cellular drug delivery. (605 citations)
- Synthetic Studies of Biologically Active Marine Cyclopeptides (421 citations)
- Fluorous Synthesis: A Fluorous-Phase Strategy for Improving Separation Efficiency in Organic Synthesis (411 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Stereochemistry, Organic chemistry, Combinatorial chemistry, Biochemistry and Cell biology.
His Stereochemistry study combines topics in areas such as Peptide and Stereoselectivity.
His study in Catalysis, Reagent, Transmetalation and Allylic rearrangement is carried out as part of his studies in Organic chemistry.
Biochemistry is a component of his Phosphatase, Kinase, Small molecule, In vitro and Dual-specificity phosphatase studies.
His research in Cell biology is mostly concerned with Mitochondrion.
His Mitochondrion study frequently draws connections to other fields, such as Reactive oxygen species.
He most often published in these fields:
- Stereochemistry (22.86%)
- Organic chemistry (15.36%)
- Combinatorial chemistry (15.24%)
What were the highlights of his more recent work (between 2015-2021)?
- Cancer research (7.15%)
- Cell biology (7.85%)
- Pharmacology (6.68%)
In recent papers he was focusing on the following fields of study:
Peter Wipf mostly deals with Cancer research, Cell biology, Pharmacology, Biochemistry and Mitochondrion.
His Cancer research study combines topics from a wide range of disciplines, such as In vitro, Fanconi anemia, FANCA, Bone marrow and Androgen receptor.
His research in In vitro intersects with topics in Cell culture, In vivo and Phosphatase.
His Cell biology study which covers Apoptosis that intersects with Lipid peroxidation.
Multidrug resistance-associated protein 2 and Protein tyrosine phosphatase are the subjects of his Biochemistry studies.
The concepts of his Mitochondrion study are interwoven with issues in Reactive oxygen species and DNA damage.
Between 2015 and 2021, his most popular works were:
- 2.3 A Resolution Cryo-Em Structure of Human P97 and Mechanism of Allosteric Inhibition (199 citations)
- A Mitochondrial-Targeted Nitroxide Is a Potent Inhibitor of Ferroptosis (82 citations)
- Spontaneous DNA damage to the nuclear genome promotes senescence, redox imbalance and aging. (45 citations)
In his most recent research, the most cited papers focused on:
- Enzyme
- Gene
- Organic chemistry
His primary areas of study are Mitochondrion, Cell biology, Reactive oxygen species, Oxidative stress and Biochemistry.
His study in the fields of Bioenergetics under the domain of Mitochondrion overlaps with other disciplines such as Transient stress.
The Cell biology study combines topics in areas such as Oxidative phosphorylation, Glutathione and DNA damage.
His Biochemistry study frequently draws connections to adjacent fields such as Molecular targets.
His Cryo-electron microscopy study frequently draws parallels with other fields, such as Stereochemistry.
His Combinatorial chemistry study incorporates themes from Total synthesis and Protein tyrosine phosphatase.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
